Endpoints News 12 feb 2026 BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
Endpoints News 11 feb 2026 How a closet full of EKG machines illustrates pharma’s clinical trial cost problem
Endpoints News 11 feb 2026 Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?